Brief: Belite Bio Announces Registered Direct Offering Of $15 Million
07/08/2025 13:36
Aug 7 (Reuters) - Belite Bio Inc BLTE.O: BELITE BIO ANNOUNCES REGISTERED DIRECT OFFERING OF $15 MILLION BELITE BIO INC - ANNOUNCES PURCHASE AGREEMENT FOR 230,770 ADSS AT $65 EACH Source text: ID:nGNX2xXR5K Further company coverage: BLTE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Belite Bio
See all newsBrief: Belite Bio Announces Uplisting To The Nasdaq Global Select Market
Brief: Belite Bio Announces Multi-Market Submission Of Marketing Authorization Applications Via The Access Consortium Pathway For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Brief: Belite Bio Announces Submission Of New Drug Application To The Ministry Of Health, Labour, And Welfare In Japan Under The Sakigake Designation System For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Belite Bio, Inc reports results for the quarter ended June 30 - Earnings Summary
Belite Bio Q2 net loss widens on higher expenses